1 completed, 1 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Unknown 1 |
Follow Fluorescein Angiography: new trials by email Literature Review of Fluorescein Angiography trials Research Report on Fluorescein Angiography
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Learn How Well a Higher Amount of Aflibercept Given as an Injection Into the Eye Works and How Safe it is in People With Reduced Vision Due to Swelling in the Macula, Central Part of the Retina Caused by a Blocked Vein in the Retina (Macula Edema Secondary to Retinal Vein Occlusion) Aflibercept, VEGF Trap-Eye(Eylea, BAY86-5321)_higher dose, Aflibercept, VEGF Trap-Eye(Eylea, BAY86-5321)_2 mg, Sham - Macular Edema Secondary to Retinal Vein Occlusion | Phase 3 | Completed | Bayer | 892 | 2023-05-15 | 2026-06-17 |
| Use of Indocyanine Green Angiography in Critical Limb Ischemia fluorescence angiography - Peripheral Arterial Disease | Phase 3 | Unknown | University Hospital, Grenoble | 30 | 2015-11-01 | 2017-03-17 |
Ischemia (1) · Peripheral Arterial Disease (1)
Bayer (1) · University Hospital, Grenoble (1)
France (2) · Australia (1) · Austria (1) · Bulgaria (1) · China (1) · Czechia (1) · Estonia (1) · Georgia (1) · Germany (1) · Hungary (1) · Israel (1) · Italy (1) · Japan (1) · Latvia (1) · Lithuania (1)